Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.760
+0.170 (3.70%)
At close: Aug 19, 2026, 4:00 PM EDT
4.810
+0.050 (1.05%)
After-hours: Aug 19, 2026, 7:30 PM EDT
Nephros Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20.72 | 18.79 | 14.16 | 14.24 | 9.98 | 10.22 | |
Revenue Growth | 24.20% | 32.67% | -0.53% | 42.74% | -2.37% | 19.34% |
Cost of Revenue | 8.03 | 7.16 | 5.44 | 5.83 | 5.24 | 4.58 |
Gross Profit | 12.7 | 11.63 | 8.72 | 8.41 | 4.73 | 5.63 |
Selling, General & Admin | 9.48 | 9 | 7.68 | 8.91 | 7.59 | 7.2 |
Research & Development | 1.45 | 1.34 | 0.91 | 0.87 | 1.26 | 1.5 |
Operating Expenses | 11.05 | 10.48 | 8.72 | 10 | 9.07 | 8.89 |
Operating Income | 1.64 | 1.15 | 0.01 | -1.59 | -4.34 | -3.25 |
Interest Expense | -0 | -0 | -0 | -0 | -0.02 | -0.04 |
Interest & Investment Income | 0.16 | 0.14 | 0.09 | 0.06 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | -0.05 | -0.08 | -0.01 | -0.04 | - | - |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.02 |
EBT Excluding Unusual Items | 1.75 | 1.21 | 0.09 | -1.58 | -4.34 | -3.27 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.06 | - |
Other Unusual Items | - | - | - | - | - | 0.48 |
Pretax Income | 1.75 | 1.21 | 0.09 | -1.58 | -4.28 | -2.78 |
Income Tax Expense | 0.02 | 0.01 | 0.02 | - | - | - |
Earnings From Continuing Operations | 1.74 | 1.19 | 0.07 | -1.58 | -4.28 | -2.78 |
Earnings From Discontinued Operations | - | - | - | - | -2.83 | -1.08 |
Net Income to Company | 1.74 | 1.19 | 0.07 | -1.58 | -7.11 | -3.87 |
Minority Interest in Earnings | - | - | - | - | -0.28 | -0.24 |
Net Income | 1.74 | 1.19 | 0.07 | -1.58 | -7.38 | -4.11 |
Net Income to Common | 1.74 | 1.19 | 0.07 | -1.58 | -7.38 | -4.11 |
Net Income Growth | 30.82% | 1513.51% | - | - | - | - |
Shares Outstanding (Basic) | 11 | 11 | 11 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 10 | 10 | 10 |
Shares Change | 4.21% | 3.45% | 2.08% | 0.86% | 2.79% | 10.35% |
EPS (Basic) | 0.16 | 0.11 | 0.01 | -0.15 | -0.72 | -0.41 |
EPS (Diluted) | 0.16 | 0.11 | 0.01 | -0.15 | -0.73 | -0.41 |
EPS Growth | 34.27% | 1464.72% | - | - | - | - |
Free Cash Flow | -0.66 | 1.65 | -0.55 | 0.75 | -3.37 | -1.5 |
Free Cash Flow Per Share | -0.06 | 0.15 | -0.05 | 0.07 | -0.33 | -0.15 |
Gross Margin | 61.26% | 61.87% | 61.59% | 59.03% | 47.43% | 55.13% |
Operating Margin | 7.92% | 6.10% | 0.04% | -11.19% | -43.46% | -31.83% |
Profit Margin | 8.38% | 6.35% | 0.52% | -11.06% | -74.00% | -40.20% |
Free Cash Flow Margin | -3.19% | 8.76% | -3.86% | 5.28% | -33.79% | -14.70% |
EBITDA | 1.76 | 1.29 | 0.14 | -1.38 | -3.98 | -3 |
EBITDA Margin | 8.51% | 6.84% | 1.01% | -9.69% | -39.94% | -29.36% |
D&A For EBITDA | 0.12 | 0.14 | 0.14 | 0.21 | 0.35 | 0.25 |
EBIT | 1.64 | 1.15 | 0.01 | -1.59 | -4.34 | -3.25 |
EBIT Margin | 7.92% | 6.10% | 0.04% | -11.19% | -43.46% | -31.83% |
Effective Tax Rate | 0.91% | 1.00% | 16.85% | - | - | - |
Revenue as Reported | 20.72 | 18.79 | 14.16 | 14.24 | 9.98 | 10.22 |